| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stress Disorders, Post-Traumatic | 244 | 2024 | 4266 | 20.780 |
Why?
|
| Fear | 127 | 2023 | 1440 | 19.470 |
Why?
|
| Extinction, Psychological | 55 | 2023 | 376 | 9.710 |
Why?
|
| Amygdala | 75 | 2024 | 1315 | 9.450 |
Why?
|
| Conditioning, Classical | 47 | 2021 | 366 | 7.610 |
Why?
|
| Brain-Derived Neurotrophic Factor | 22 | 2015 | 604 | 4.280 |
Why?
|
| Tacrolimus Binding Proteins | 15 | 2021 | 195 | 4.080 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 14 | 2022 | 52 | 3.960 |
Why?
|
| Memory | 28 | 2019 | 2174 | 3.700 |
Why?
|
| Implosive Therapy | 12 | 2021 | 120 | 3.630 |
Why?
|
| Child Abuse | 35 | 2022 | 1030 | 3.460 |
Why?
|
| Anxiety Disorders | 27 | 2023 | 2690 | 3.070 |
Why?
|
| Learning | 19 | 2023 | 1713 | 2.880 |
Why?
|
| Corticotropin-Releasing Hormone | 19 | 2021 | 369 | 2.750 |
Why?
|
| Cycloserine | 11 | 2019 | 113 | 2.510 |
Why?
|
| Brain | 71 | 2023 | 26385 | 2.380 |
Why?
|
| Dissociative Disorders | 9 | 2022 | 231 | 2.290 |
Why?
|
| Receptor, trkB | 11 | 2017 | 125 | 2.270 |
Why?
|
| Adult Survivors of Child Abuse | 14 | 2021 | 260 | 2.250 |
Why?
|
| Epigenesis, Genetic | 31 | 2023 | 3647 | 2.220 |
Why?
|
| Anxiety | 32 | 2023 | 4297 | 2.170 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 9 | 2024 | 102 | 2.070 |
Why?
|
| Stress, Psychological | 26 | 2023 | 4245 | 2.050 |
Why?
|
| Life Change Events | 19 | 2021 | 938 | 1.910 |
Why?
|
| Behavior | 4 | 2023 | 561 | 1.890 |
Why?
|
| Prefrontal Cortex | 19 | 2023 | 2147 | 1.800 |
Why?
|
| Hippocampus | 25 | 2022 | 3675 | 1.780 |
Why?
|
| Neural Pathways | 17 | 2023 | 2972 | 1.760 |
Why?
|
| Neuronal Plasticity | 16 | 2022 | 1422 | 1.750 |
Why?
|
| Urban Population | 21 | 2017 | 2021 | 1.710 |
Why?
|
| Anti-Anxiety Agents | 6 | 2014 | 390 | 1.680 |
Why?
|
| Receptors, GABA-A | 7 | 2013 | 627 | 1.680 |
Why?
|
| Association Learning | 9 | 2015 | 224 | 1.670 |
Why?
|
| Depressive Disorder, Major | 27 | 2023 | 4644 | 1.670 |
Why?
|
| Epigenomics | 11 | 2023 | 903 | 1.650 |
Why?
|
| Resilience, Psychological | 12 | 2021 | 676 | 1.640 |
Why?
|
| Veterans | 18 | 2023 | 2519 | 1.580 |
Why?
|
| Alprazolam | 4 | 2016 | 98 | 1.520 |
Why?
|
| Neurons | 27 | 2024 | 9338 | 1.510 |
Why?
|
| Behavior, Animal | 22 | 2023 | 1881 | 1.490 |
Why?
|
| Genetic Predisposition to Disease | 48 | 2023 | 17446 | 1.440 |
Why?
|
| Polymorphism, Single Nucleotide | 47 | 2022 | 15519 | 1.400 |
Why?
|
| Mental Disorders | 19 | 2021 | 6600 | 1.390 |
Why?
|
| Hypothalamo-Hypophyseal System | 12 | 2022 | 703 | 1.370 |
Why?
|
| Animals | 165 | 2024 | 168757 | 1.370 |
Why?
|
| Cholecystokinin | 5 | 2014 | 114 | 1.360 |
Why?
|
| Phobic Disorders | 6 | 2014 | 439 | 1.350 |
Why?
|
| Depression | 33 | 2023 | 7766 | 1.340 |
Why?
|
| Pituitary-Adrenal System | 12 | 2022 | 553 | 1.340 |
Why?
|
| DNA Methylation | 27 | 2022 | 4286 | 1.340 |
Why?
|
| Wounds and Injuries | 16 | 2021 | 2400 | 1.330 |
Why?
|
| Emotions | 19 | 2023 | 2661 | 1.320 |
Why?
|
| Receptor, Cannabinoid, CB1 | 4 | 2015 | 143 | 1.310 |
Why?
|
| Olfactory Pathways | 6 | 2013 | 121 | 1.280 |
Why?
|
| Military Personnel | 11 | 2023 | 1133 | 1.260 |
Why?
|
| Genome-Wide Association Study | 43 | 2024 | 12261 | 1.240 |
Why?
|
| Humans | 372 | 2024 | 744343 | 1.240 |
Why?
|
| Tachykinins | 3 | 2018 | 78 | 1.180 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 7 | 2018 | 87 | 1.170 |
Why?
|
| Male | 246 | 2024 | 350118 | 1.170 |
Why?
|
| Smell | 7 | 2014 | 244 | 1.150 |
Why?
|
| Receptors, Glucocorticoid | 7 | 2021 | 302 | 1.120 |
Why?
|
| Autonomic Nervous System | 4 | 2022 | 671 | 1.100 |
Why?
|
| Cues | 14 | 2023 | 873 | 1.100 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 4 | 2015 | 322 | 1.100 |
Why?
|
| Gene Expression Regulation | 27 | 2021 | 12072 | 1.090 |
Why?
|
| Mice | 93 | 2024 | 81183 | 1.080 |
Why?
|
| Mice, Inbred C57BL | 48 | 2023 | 21827 | 1.070 |
Why?
|
| Social Environment | 6 | 2016 | 1023 | 1.020 |
Why?
|
| Alcoholism | 7 | 2022 | 1906 | 1.010 |
Why?
|
| Neurosciences | 5 | 2019 | 348 | 1.010 |
Why?
|
| Receptors, Odorant | 13 | 2018 | 61 | 0.990 |
Why?
|
| Sex Characteristics | 11 | 2019 | 2585 | 0.990 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 7 | 2015 | 895 | 0.960 |
Why?
|
| Female | 225 | 2024 | 380194 | 0.960 |
Why?
|
| Adult | 170 | 2023 | 214055 | 0.960 |
Why?
|
| Maze Learning | 8 | 2013 | 478 | 0.930 |
Why?
|
| Septal Nuclei | 6 | 2015 | 85 | 0.920 |
Why?
|
| Obsessive-Compulsive Disorder | 5 | 2023 | 1444 | 0.920 |
Why?
|
| Freezing Reaction, Cataleptic | 6 | 2015 | 42 | 0.910 |
Why?
|
| Nerve Net | 16 | 2023 | 2174 | 0.900 |
Why?
|
| Psychiatry | 5 | 2020 | 1695 | 0.890 |
Why?
|
| Georgia | 14 | 2017 | 186 | 0.880 |
Why?
|
| Protein Precursors | 3 | 2018 | 1154 | 0.880 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2023 | 129 | 0.870 |
Why?
|
| Inheritance Patterns | 2 | 2015 | 340 | 0.870 |
Why?
|
| Substance-Related Disorders | 9 | 2023 | 4258 | 0.860 |
Why?
|
| Olfactory Bulb | 5 | 2019 | 200 | 0.860 |
Why?
|
| beta Catenin | 4 | 2012 | 1059 | 0.850 |
Why?
|
| Poverty | 8 | 2013 | 2660 | 0.850 |
Why?
|
| Genotype | 27 | 2021 | 12951 | 0.850 |
Why?
|
| Gyrus Cinguli | 8 | 2023 | 1091 | 0.840 |
Why?
|
| Receptor, Cholecystokinin B | 2 | 2014 | 7 | 0.840 |
Why?
|
| Lentivirus | 8 | 2014 | 501 | 0.840 |
Why?
|
| Genetic Association Studies | 9 | 2019 | 2703 | 0.830 |
Why?
|
| Stress Disorders, Traumatic | 2 | 2019 | 53 | 0.820 |
Why?
|
| Blinking | 3 | 2020 | 138 | 0.820 |
Why?
|
| Hydrocortisone | 12 | 2022 | 1826 | 0.820 |
Why?
|
| Stress, Physiological | 4 | 2021 | 1403 | 0.810 |
Why?
|
| Dexamethasone | 15 | 2020 | 1951 | 0.760 |
Why?
|
| Depressive Disorder | 8 | 2017 | 3748 | 0.760 |
Why?
|
| Locomotion | 4 | 2016 | 378 | 0.750 |
Why?
|
| Juvenile Delinquency | 1 | 2021 | 125 | 0.740 |
Why?
|
| Criminals | 1 | 2021 | 62 | 0.740 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2020 | 514 | 0.730 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2021 | 164 | 0.720 |
Why?
|
| Habituation, Psychophysiologic | 4 | 2016 | 154 | 0.720 |
Why?
|
| Receptors, Dopamine D2 | 3 | 2021 | 475 | 0.710 |
Why?
|
| Mood Disorders | 7 | 2013 | 1106 | 0.710 |
Why?
|
| Piperidines | 9 | 2016 | 1602 | 0.710 |
Why?
|
| Glutamate Decarboxylase | 3 | 2012 | 245 | 0.710 |
Why?
|
| Exploratory Behavior | 4 | 2015 | 270 | 0.710 |
Why?
|
| Violence | 6 | 2023 | 909 | 0.700 |
Why?
|
| Young Adult | 70 | 2023 | 56430 | 0.700 |
Why?
|
| Middle Aged | 126 | 2023 | 213383 | 0.690 |
Why?
|
| Attention | 7 | 2019 | 2400 | 0.660 |
Why?
|
| Acoustic Stimulation | 8 | 2016 | 1216 | 0.660 |
Why?
|
| Child Abuse, Sexual | 3 | 2010 | 383 | 0.660 |
Why?
|
| Arousal | 6 | 2019 | 1165 | 0.650 |
Why?
|
| Psychiatric Status Rating Scales | 24 | 2021 | 6038 | 0.650 |
Why?
|
| Facial Expression | 10 | 2019 | 508 | 0.650 |
Why?
|
| Angiotensins | 2 | 2018 | 151 | 0.640 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 11 | 2021 | 1953 | 0.640 |
Why?
|
| Synaptic Transmission | 6 | 2014 | 1178 | 0.640 |
Why?
|
| Afghan Campaign 2001- | 2 | 2017 | 272 | 0.640 |
Why?
|
| Diffusion Tensor Imaging | 13 | 2022 | 2305 | 0.640 |
Why?
|
| Signal Transduction | 19 | 2019 | 23403 | 0.630 |
Why?
|
| Mice, Transgenic | 20 | 2021 | 9734 | 0.630 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 2018 | 149 | 0.620 |
Why?
|
| Receptors, Neurokinin-3 | 2 | 2016 | 54 | 0.620 |
Why?
|
| Desensitization, Psychologic | 2 | 2010 | 28 | 0.620 |
Why?
|
| Disease Susceptibility | 3 | 2021 | 1782 | 0.620 |
Why?
|
| Adolescent | 75 | 2023 | 85781 | 0.620 |
Why?
|
| Avoidance Learning | 5 | 2017 | 233 | 0.620 |
Why?
|
| Parenting | 1 | 2024 | 679 | 0.620 |
Why?
|
| Vagus Nerve | 1 | 2020 | 438 | 0.620 |
Why?
|
| Disease Models, Animal | 19 | 2019 | 18029 | 0.610 |
Why?
|
| RNA, Messenger | 24 | 2021 | 13033 | 0.600 |
Why?
|
| Olfactory Mucosa | 4 | 2015 | 98 | 0.600 |
Why?
|
| Losartan | 3 | 2021 | 299 | 0.580 |
Why?
|
| Geriatric Psychiatry | 1 | 2017 | 70 | 0.580 |
Why?
|
| Combat Disorders | 2 | 2017 | 302 | 0.580 |
Why?
|
| Brain Mapping | 12 | 2023 | 6669 | 0.580 |
Why?
|
| Transfection | 5 | 2013 | 5892 | 0.570 |
Why?
|
| MicroRNAs | 4 | 2019 | 3752 | 0.570 |
Why?
|
| Pleasure | 1 | 2016 | 41 | 0.570 |
Why?
|
| Magnetic Resonance Imaging | 44 | 2023 | 35421 | 0.560 |
Why?
|
| Cerebrum | 2 | 2016 | 137 | 0.550 |
Why?
|
| Happiness | 2 | 2016 | 170 | 0.540 |
Why?
|
| Nausea | 1 | 2018 | 673 | 0.530 |
Why?
|
| Sodium Channels | 1 | 2017 | 349 | 0.530 |
Why?
|
| Renin-Angiotensin System | 3 | 2020 | 759 | 0.520 |
Why?
|
| Angiotensin Receptor Antagonists | 4 | 2021 | 924 | 0.520 |
Why?
|
| Mammals | 4 | 2022 | 1143 | 0.510 |
Why?
|
| Carrier Proteins | 8 | 2015 | 5021 | 0.510 |
Why?
|
| Galvanic Skin Response | 4 | 2021 | 349 | 0.500 |
Why?
|
| Dendritic Spines | 2 | 2018 | 233 | 0.500 |
Why?
|
| Sensory Receptor Cells | 3 | 2016 | 492 | 0.500 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2016 | 265 | 0.490 |
Why?
|
| Evoked Potentials | 1 | 2020 | 1056 | 0.490 |
Why?
|
| Toxoplasmosis | 3 | 2021 | 91 | 0.490 |
Why?
|
| Heart Rate | 5 | 2020 | 4091 | 0.480 |
Why?
|
| Affect | 4 | 2018 | 1476 | 0.480 |
Why?
|
| C-Reactive Protein | 7 | 2024 | 3778 | 0.480 |
Why?
|
| Neurokinin B | 1 | 2014 | 67 | 0.470 |
Why?
|
| Transcranial Magnetic Stimulation | 3 | 2021 | 1432 | 0.470 |
Why?
|
| Proteoglycans | 1 | 2017 | 835 | 0.470 |
Why?
|
| Ribonuclease III | 1 | 2015 | 275 | 0.470 |
Why?
|
| CpG Islands | 14 | 2022 | 1172 | 0.470 |
Why?
|
| Child | 52 | 2023 | 77709 | 0.460 |
Why?
|
| Patch-Clamp Techniques | 5 | 2023 | 964 | 0.460 |
Why?
|
| Nootropic Agents | 1 | 2014 | 160 | 0.460 |
Why?
|
| Neuropeptide Y | 2 | 2012 | 200 | 0.460 |
Why?
|
| Olfactory Receptor Neurons | 4 | 2008 | 92 | 0.460 |
Why?
|
| Auditory Cortex | 1 | 2017 | 346 | 0.460 |
Why?
|
| Geniculate Bodies | 1 | 2014 | 163 | 0.450 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2020 | 1518 | 0.450 |
Why?
|
| Receptors, GABA | 1 | 2015 | 288 | 0.450 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2015 | 365 | 0.450 |
Why?
|
| Polyethyleneimine | 1 | 2013 | 63 | 0.450 |
Why?
|
| Paternal Exposure | 1 | 2013 | 89 | 0.450 |
Why?
|
| Glutamic Acid | 4 | 2023 | 1169 | 0.450 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2013 | 62 | 0.440 |
Why?
|
| Electric Stimulation Therapy | 1 | 2019 | 605 | 0.440 |
Why?
|
| Proteomics | 4 | 2023 | 3638 | 0.440 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2015 | 375 | 0.440 |
Why?
|
| Receptors, Opioid | 1 | 2013 | 155 | 0.440 |
Why?
|
| Rats | 28 | 2021 | 24260 | 0.440 |
Why?
|
| Neurobiology | 1 | 2013 | 121 | 0.430 |
Why?
|
| In Situ Hybridization | 11 | 2012 | 1950 | 0.430 |
Why?
|
| Accidents, Traffic | 7 | 2022 | 819 | 0.430 |
Why?
|
| Photic Stimulation | 9 | 2016 | 2025 | 0.430 |
Why?
|
| Estradiol | 3 | 2017 | 2020 | 0.430 |
Why?
|
| Panic Disorder | 3 | 2013 | 616 | 0.430 |
Why?
|
| Models, Genetic | 6 | 2019 | 3494 | 0.430 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2015 | 789 | 0.420 |
Why?
|
| Opioid Peptides | 1 | 2012 | 42 | 0.420 |
Why?
|
| Insanity Defense | 1 | 2012 | 27 | 0.420 |
Why?
|
| Corpus Striatum | 6 | 2024 | 1221 | 0.420 |
Why?
|
| Promoter Regions, Genetic | 6 | 2014 | 5867 | 0.410 |
Why?
|
| Personality Inventory | 7 | 2013 | 1030 | 0.410 |
Why?
|
| Lipoproteins, LDL | 2 | 2022 | 640 | 0.410 |
Why?
|
| Appetite | 1 | 2014 | 243 | 0.410 |
Why?
|
| Risk Factors | 46 | 2023 | 72290 | 0.410 |
Why?
|
| Stress Disorders, Traumatic, Acute | 1 | 2011 | 28 | 0.410 |
Why?
|
| Wnt Proteins | 2 | 2016 | 721 | 0.400 |
Why?
|
| Alleles | 12 | 2023 | 6933 | 0.400 |
Why?
|
| Environment | 3 | 2016 | 1124 | 0.400 |
Why?
|
| Neuropsychological Tests | 11 | 2017 | 6993 | 0.400 |
Why?
|
| Wnt1 Protein | 1 | 2011 | 118 | 0.400 |
Why?
|
| Sex Factors | 14 | 2022 | 10397 | 0.400 |
Why?
|
| Patient Care Planning | 1 | 2017 | 921 | 0.390 |
Why?
|
| Risperidone | 1 | 2013 | 383 | 0.390 |
Why?
|
| Feeding Behavior | 2 | 2023 | 3188 | 0.390 |
Why?
|
| Corticosterone | 6 | 2021 | 310 | 0.390 |
Why?
|
| Lipoproteins, HDL | 2 | 2022 | 638 | 0.380 |
Why?
|
| Flavanones | 1 | 2010 | 71 | 0.380 |
Why?
|
| Polymorphism, Genetic | 5 | 2016 | 4328 | 0.380 |
Why?
|
| Suicide, Attempted | 4 | 2014 | 1221 | 0.380 |
Why?
|
| Analysis of Variance | 11 | 2015 | 6365 | 0.380 |
Why?
|
| gamma-Aminobutyric Acid | 3 | 2012 | 1121 | 0.370 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 451 | 0.370 |
Why?
|
| Genetic Variation | 6 | 2018 | 6544 | 0.370 |
Why?
|
| Neurotensin | 2 | 2022 | 61 | 0.370 |
Why?
|
| Emergency Service, Hospital | 8 | 2023 | 7659 | 0.360 |
Why?
|
| Phenotype | 20 | 2024 | 16365 | 0.360 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 4 | 2018 | 173 | 0.360 |
Why?
|
| Green Fluorescent Proteins | 8 | 2016 | 2088 | 0.350 |
Why?
|
| Chromosomal Proteins, Non-Histone | 3 | 2024 | 736 | 0.350 |
Why?
|
| Suicide | 3 | 2016 | 1477 | 0.350 |
Why?
|
| Receptors, Notch | 1 | 2014 | 739 | 0.350 |
Why?
|
| Longitudinal Studies | 18 | 2023 | 13989 | 0.350 |
Why?
|
| Hypnosis | 1 | 2010 | 82 | 0.350 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 1741 | 0.340 |
Why?
|
| Affective Symptoms | 3 | 2016 | 407 | 0.340 |
Why?
|
| Nerve Tissue Proteins | 6 | 2015 | 4462 | 0.340 |
Why?
|
| Expert Testimony | 1 | 2012 | 356 | 0.340 |
Why?
|
| Mental Recall | 4 | 2016 | 1205 | 0.340 |
Why?
|
| Face | 1 | 2015 | 994 | 0.340 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2013 | 2455 | 0.340 |
Why?
|
| Psychopathology | 4 | 2023 | 409 | 0.330 |
Why?
|
| Sensory Gating | 1 | 2009 | 47 | 0.330 |
Why?
|
| Rats, Sprague-Dawley | 17 | 2021 | 8301 | 0.330 |
Why?
|
| Antipsychotic Agents | 3 | 2016 | 3057 | 0.330 |
Why?
|
| Nonlinear Dynamics | 1 | 2011 | 502 | 0.330 |
Why?
|
| Community Mental Health Centers | 2 | 2008 | 102 | 0.330 |
Why?
|
| Electroconvulsive Therapy | 3 | 2021 | 477 | 0.330 |
Why?
|
| Cross-Sectional Studies | 22 | 2023 | 25043 | 0.330 |
Why?
|
| Temporal Lobe | 5 | 2020 | 1670 | 0.330 |
Why?
|
| Acetophenones | 5 | 2018 | 48 | 0.330 |
Why?
|
| Psychophysiology | 2 | 2021 | 135 | 0.320 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 3 | 2021 | 113 | 0.320 |
Why?
|
| Dependovirus | 1 | 2013 | 706 | 0.320 |
Why?
|
| Severity of Illness Index | 17 | 2019 | 15540 | 0.310 |
Why?
|
| Comprehension | 1 | 2013 | 610 | 0.310 |
Why?
|
| Toxoplasma | 2 | 2021 | 150 | 0.310 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2011 | 365 | 0.310 |
Why?
|
| Molecular Biology | 1 | 2012 | 596 | 0.310 |
Why?
|
| Synapses | 3 | 2012 | 1728 | 0.310 |
Why?
|
| Motor Vehicles | 7 | 2023 | 268 | 0.310 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 957 | 0.300 |
Why?
|
| Models, Neurological | 3 | 2014 | 1774 | 0.300 |
Why?
|
| Integrases | 4 | 2016 | 533 | 0.300 |
Why?
|
| Endocannabinoids | 1 | 2008 | 116 | 0.300 |
Why?
|
| Receptors, Cannabinoid | 1 | 2007 | 44 | 0.300 |
Why?
|
| Triglycerides | 2 | 2022 | 2454 | 0.300 |
Why?
|
| Estrogens | 5 | 2017 | 1566 | 0.300 |
Why?
|
| Quantitative Trait Loci | 4 | 2016 | 2019 | 0.300 |
Why?
|
| Patient Discharge | 2 | 2019 | 3313 | 0.290 |
Why?
|
| Norepinephrine | 2 | 2000 | 909 | 0.290 |
Why?
|
| Phylogeny | 1 | 2014 | 2803 | 0.290 |
Why?
|
| Mice, Knockout | 12 | 2018 | 14557 | 0.290 |
Why?
|
| Benzodiazepines | 2 | 2010 | 1101 | 0.290 |
Why?
|
| Spatial Behavior | 1 | 2007 | 90 | 0.290 |
Why?
|
| Aged | 52 | 2023 | 163280 | 0.290 |
Why?
|
| Electrophysiological Phenomena | 1 | 2009 | 315 | 0.290 |
Why?
|
| Protein Kinase C-delta | 2 | 2018 | 123 | 0.290 |
Why?
|
| Hypothalamus | 6 | 2022 | 1063 | 0.280 |
Why?
|
| Motor Activity | 6 | 2018 | 2714 | 0.280 |
Why?
|
| Combined Modality Therapy | 7 | 2019 | 8642 | 0.270 |
Why?
|
| Genetic Loci | 2 | 2019 | 2575 | 0.270 |
Why?
|
| Dyslipidemias | 1 | 2013 | 849 | 0.270 |
Why?
|
| GABA Modulators | 1 | 2006 | 107 | 0.270 |
Why?
|
| Mice, Mutant Strains | 4 | 2014 | 1866 | 0.270 |
Why?
|
| Minority Groups | 1 | 2013 | 1223 | 0.270 |
Why?
|
| Dopamine | 3 | 2018 | 1591 | 0.270 |
Why?
|
| Habenula | 1 | 2006 | 38 | 0.270 |
Why?
|
| Citalopram | 3 | 2015 | 403 | 0.270 |
Why?
|
| Histone Deacetylases | 3 | 2017 | 728 | 0.270 |
Why?
|
| Length of Stay | 1 | 2019 | 6309 | 0.270 |
Why?
|
| Mesencephalon | 1 | 2007 | 329 | 0.260 |
Why?
|
| Prosencephalon | 1 | 2007 | 303 | 0.260 |
Why?
|
| Electromyography | 6 | 2018 | 1379 | 0.260 |
Why?
|
| Cardiovascular Diseases | 5 | 2023 | 15165 | 0.260 |
Why?
|
| Gene Deletion | 4 | 2021 | 2751 | 0.260 |
Why?
|
| Genes, Reporter | 3 | 2016 | 1547 | 0.260 |
Why?
|
| Down-Regulation | 5 | 2020 | 3002 | 0.250 |
Why?
|
| Glucocorticoids | 7 | 2023 | 2107 | 0.250 |
Why?
|
| Schizophrenia | 7 | 2023 | 6882 | 0.250 |
Why?
|
| Prospective Studies | 18 | 2023 | 53288 | 0.250 |
Why?
|
| Psychometrics | 6 | 2021 | 3002 | 0.250 |
Why?
|
| Genetic Vectors | 6 | 2013 | 3420 | 0.250 |
Why?
|
| Anisotropy | 4 | 2021 | 1265 | 0.250 |
Why?
|
| Demography | 5 | 2021 | 1656 | 0.240 |
Why?
|
| Social Behavior | 5 | 2023 | 1127 | 0.240 |
Why?
|
| Midazolam | 1 | 2006 | 270 | 0.240 |
Why?
|
| Membrane Glycoproteins | 2 | 2012 | 3768 | 0.240 |
Why?
|
| Adaptation, Psychological | 5 | 2017 | 2576 | 0.240 |
Why?
|
| Wrist | 2 | 2023 | 224 | 0.240 |
Why?
|
| Flavones | 3 | 2017 | 66 | 0.240 |
Why?
|
| Crime | 2 | 2015 | 215 | 0.240 |
Why?
|
| Psychomotor Performance | 1 | 2012 | 1901 | 0.240 |
Why?
|
| Pain | 5 | 2023 | 4986 | 0.240 |
Why?
|
| Genetic Markers | 5 | 2016 | 2634 | 0.240 |
Why?
|
| Tetrazoles | 1 | 2009 | 835 | 0.240 |
Why?
|
| Protein Subunits | 1 | 2007 | 959 | 0.230 |
Why?
|
| Urban Health Services | 1 | 2005 | 179 | 0.230 |
Why?
|
| Melanocortins | 1 | 2023 | 11 | 0.230 |
Why?
|
| Analgesics, Opioid | 3 | 2022 | 3674 | 0.230 |
Why?
|
| Trauma Severity Indices | 3 | 2021 | 481 | 0.230 |
Why?
|
| Telemedicine | 2 | 2019 | 2872 | 0.230 |
Why?
|
| Gene Expression | 10 | 2019 | 7799 | 0.230 |
Why?
|
| Thalamus | 3 | 2019 | 1023 | 0.220 |
Why?
|
| Excitatory Amino Acid Agonists | 3 | 2017 | 146 | 0.220 |
Why?
|
| Self Report | 10 | 2020 | 3558 | 0.220 |
Why?
|
| Receptors, AMPA | 2 | 2015 | 331 | 0.220 |
Why?
|
| Hashimoto Disease | 1 | 2024 | 97 | 0.220 |
Why?
|
| Gene Frequency | 6 | 2021 | 3588 | 0.220 |
Why?
|
| Aggression | 3 | 2019 | 753 | 0.220 |
Why?
|
| Cohort Studies | 20 | 2021 | 40561 | 0.220 |
Why?
|
| Receptors, Adrenergic, beta-2 | 4 | 2015 | 202 | 0.220 |
Why?
|
| Inflammation | 8 | 2023 | 10638 | 0.220 |
Why?
|
| Response Elements | 3 | 2015 | 312 | 0.210 |
Why?
|
| Antihypertensive Agents | 1 | 2012 | 2046 | 0.210 |
Why?
|
| Electroshock | 4 | 2013 | 122 | 0.210 |
Why?
|
| Survivors | 5 | 2024 | 2291 | 0.210 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 2014 | 8949 | 0.210 |
Why?
|
| Hypnotics and Sedatives | 1 | 2010 | 1162 | 0.210 |
Why?
|
| Cognition | 5 | 2021 | 6770 | 0.210 |
Why?
|
| Precipitating Factors | 1 | 2021 | 52 | 0.200 |
Why?
|
| Neural Inhibition | 1 | 2006 | 602 | 0.200 |
Why?
|
| Linkage Disequilibrium | 7 | 2021 | 1997 | 0.200 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2019 | 2408 | 0.200 |
Why?
|
| Punishment | 1 | 2022 | 98 | 0.200 |
Why?
|
| Membrane Proteins | 4 | 2013 | 7880 | 0.200 |
Why?
|
| Pyrazoles | 4 | 2015 | 1972 | 0.200 |
Why?
|
| Dreams | 1 | 2022 | 147 | 0.200 |
Why?
|
| Reward | 3 | 2023 | 941 | 0.190 |
Why?
|
| Socioeconomic Factors | 6 | 2012 | 7785 | 0.190 |
Why?
|
| Repressor Proteins | 4 | 2020 | 3023 | 0.190 |
Why?
|
| Cerebral Cortex | 4 | 2023 | 5708 | 0.190 |
Why?
|
| Ventral Tegmental Area | 2 | 2019 | 142 | 0.190 |
Why?
|
| Immobilization | 2 | 2013 | 236 | 0.190 |
Why?
|
| Models, Animal | 3 | 2020 | 2171 | 0.190 |
Why?
|
| Hospitals, Psychiatric | 2 | 2019 | 332 | 0.190 |
Why?
|
| Criminal Law | 1 | 2021 | 96 | 0.190 |
Why?
|
| Aging | 6 | 2023 | 8664 | 0.190 |
Why?
|
| Statistics as Topic | 3 | 2013 | 2373 | 0.190 |
Why?
|
| Treatment Outcome | 18 | 2021 | 63114 | 0.190 |
Why?
|
| Depersonalization | 1 | 2020 | 39 | 0.190 |
Why?
|
| Double-Blind Method | 6 | 2021 | 12026 | 0.190 |
Why?
|
| Bullying | 1 | 2023 | 210 | 0.180 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2020 | 72 | 0.180 |
Why?
|
| Anticonvulsants | 1 | 2010 | 1916 | 0.180 |
Why?
|
| Rape | 2 | 2012 | 133 | 0.180 |
Why?
|
| Interneurons | 2 | 2019 | 577 | 0.180 |
Why?
|
| Habits | 2 | 2017 | 139 | 0.180 |
Why?
|
| Individuality | 1 | 2021 | 307 | 0.180 |
Why?
|
| Psychotherapy | 4 | 2023 | 1643 | 0.180 |
Why?
|
| Models, Psychological | 3 | 2016 | 811 | 0.180 |
Why?
|
| Psychotropic Drugs | 2 | 2015 | 894 | 0.180 |
Why?
|
| Isoenzymes | 1 | 2004 | 1726 | 0.170 |
Why?
|
| Cholinergic Agents | 1 | 2019 | 93 | 0.170 |
Why?
|
| Scopolamine | 1 | 2019 | 99 | 0.170 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 2012 | 0.170 |
Why?
|
| Pituitary-Adrenal Function Tests | 4 | 2012 | 31 | 0.170 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 7913 | 0.170 |
Why?
|
| Crime Victims | 1 | 2023 | 322 | 0.170 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2021 | 291 | 0.170 |
Why?
|
| Alternative Splicing | 1 | 2004 | 1117 | 0.170 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2014 | 2649 | 0.170 |
Why?
|
| Genes, fos | 1 | 2019 | 183 | 0.170 |
Why?
|
| Antidepressive Agents | 4 | 2017 | 2838 | 0.170 |
Why?
|
| Cannabis | 2 | 2023 | 439 | 0.170 |
Why?
|
| Endocrine System | 1 | 2019 | 113 | 0.170 |
Why?
|
| Receptor, Serotonin, 5-HT2B | 1 | 2018 | 6 | 0.170 |
Why?
|
| Risk Assessment | 4 | 2021 | 23338 | 0.160 |
Why?
|
| GABA-A Receptor Agonists | 2 | 2017 | 84 | 0.160 |
Why?
|
| Injections, Intraventricular | 2 | 2016 | 230 | 0.160 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2016 | 10943 | 0.160 |
Why?
|
| Opioid-Related Disorders | 2 | 2024 | 2065 | 0.160 |
Why?
|
| Microinjections | 2 | 2011 | 327 | 0.160 |
Why?
|
| Clozapine | 2 | 2016 | 498 | 0.160 |
Why?
|
| Cytokines | 2 | 2024 | 7322 | 0.160 |
Why?
|
| Nucleus Accumbens | 1 | 2021 | 366 | 0.160 |
Why?
|
| Ethanol | 2 | 2022 | 1342 | 0.160 |
Why?
|
| Calcium Signaling | 1 | 2023 | 721 | 0.160 |
Why?
|
| Ondansetron | 1 | 2018 | 90 | 0.160 |
Why?
|
| Social Class | 2 | 2019 | 1999 | 0.160 |
Why?
|
| Neuregulin-1 | 1 | 2018 | 142 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2020 | 4420 | 0.160 |
Why?
|
| Biomedical Research | 1 | 2013 | 3309 | 0.150 |
Why?
|
| Risk | 7 | 2019 | 9687 | 0.150 |
Why?
|
| Cell Line | 7 | 2016 | 15997 | 0.150 |
Why?
|
| Linguistics | 1 | 2018 | 97 | 0.150 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2018 | 144 | 0.150 |
Why?
|
| Multifactorial Inheritance | 3 | 2021 | 1194 | 0.150 |
Why?
|
| Muscimol | 1 | 2017 | 69 | 0.150 |
Why?
|
| Designer Drugs | 1 | 2017 | 20 | 0.150 |
Why?
|
| Cells, Cultured | 6 | 2021 | 19229 | 0.150 |
Why?
|
| Comorbidity | 8 | 2023 | 10388 | 0.150 |
Why?
|
| Body Weights and Measures | 1 | 2017 | 211 | 0.150 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2017 | 1222 | 0.150 |
Why?
|
| Telemetry | 1 | 2018 | 205 | 0.150 |
Why?
|
| Regression Analysis | 6 | 2014 | 6459 | 0.150 |
Why?
|
| Cytoskeletal Proteins | 2 | 2020 | 1364 | 0.150 |
Why?
|
| Antiemetics | 1 | 2018 | 177 | 0.150 |
Why?
|
| Bipolar Disorder | 4 | 2017 | 5027 | 0.150 |
Why?
|
| Receptors, Neurotensin | 1 | 2016 | 18 | 0.150 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2016 | 1676 | 0.140 |
Why?
|
| Racemases and Epimerases | 1 | 2017 | 113 | 0.140 |
Why?
|
| Mouth Mucosa | 1 | 2019 | 434 | 0.140 |
Why?
|
| N-Methylaspartate | 1 | 2017 | 231 | 0.140 |
Why?
|
| Urban Health | 3 | 2018 | 547 | 0.140 |
Why?
|
| Immunohistochemistry | 6 | 2017 | 11366 | 0.140 |
Why?
|
| Genomics | 8 | 2021 | 5720 | 0.140 |
Why?
|
| Eating | 1 | 2023 | 1536 | 0.140 |
Why?
|
| Introns | 2 | 2016 | 991 | 0.140 |
Why?
|
| Patient Dropouts | 1 | 2018 | 421 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2016 | 66 | 0.140 |
Why?
|
| Interview, Psychological | 2 | 2017 | 812 | 0.140 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2019 | 780 | 0.140 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2016 | 53 | 0.140 |
Why?
|
| Thrombospondins | 1 | 2016 | 197 | 0.140 |
Why?
|
| Autophagy | 1 | 2024 | 1300 | 0.140 |
Why?
|
| Narration | 1 | 2018 | 212 | 0.140 |
Why?
|
| Sexual Maturation | 1 | 2017 | 265 | 0.140 |
Why?
|
| Somatostatin | 1 | 2018 | 459 | 0.130 |
Why?
|
| Safety | 1 | 2021 | 1186 | 0.130 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2282 | 0.130 |
Why?
|
| Calcium Channels, L-Type | 1 | 2017 | 240 | 0.130 |
Why?
|
| Haplotypes | 3 | 2019 | 2779 | 0.130 |
Why?
|
| Alcohol Drinking | 3 | 2022 | 3966 | 0.130 |
Why?
|
| Case-Control Studies | 12 | 2022 | 21746 | 0.130 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2017 | 337 | 0.130 |
Why?
|
| Receptors, Oxytocin | 1 | 2016 | 66 | 0.130 |
Why?
|
| Child Behavior | 1 | 2021 | 839 | 0.130 |
Why?
|
| Gene Expression Profiling | 7 | 2024 | 9438 | 0.130 |
Why?
|
| Residence Characteristics | 3 | 2015 | 2050 | 0.130 |
Why?
|
| Cadherins | 2 | 2011 | 907 | 0.130 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2015 | 65 | 0.130 |
Why?
|
| Data Interpretation, Statistical | 2 | 2016 | 2716 | 0.130 |
Why?
|
| Decision Making | 3 | 2015 | 3887 | 0.130 |
Why?
|
| Serotonin | 1 | 2000 | 1017 | 0.130 |
Why?
|
| Adjustment Disorders | 1 | 2015 | 70 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 2 | 2016 | 1526 | 0.130 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2016 | 310 | 0.130 |
Why?
|
| Linear Models | 5 | 2017 | 5952 | 0.130 |
Why?
|
| Memory Disorders | 2 | 2013 | 1184 | 0.130 |
Why?
|
| Histone Deacetylase 2 | 1 | 2015 | 74 | 0.130 |
Why?
|
| Gene Targeting | 2 | 2010 | 880 | 0.130 |
Why?
|
| Receptors, Glutamate | 2 | 2006 | 232 | 0.130 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2015 | 152 | 0.130 |
Why?
|
| Marijuana Smoking | 1 | 2018 | 253 | 0.130 |
Why?
|
| Technology | 1 | 2017 | 305 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 1114 | 0.120 |
Why?
|
| Culture | 1 | 2019 | 633 | 0.120 |
Why?
|
| Child of Impaired Parents | 1 | 2018 | 455 | 0.120 |
Why?
|
| Hyperphagia | 1 | 2015 | 136 | 0.120 |
Why?
|
| Valproic Acid | 1 | 2017 | 445 | 0.120 |
Why?
|
| Developmental Disabilities | 1 | 2003 | 1456 | 0.120 |
Why?
|
| Tolloid-Like Metalloproteinases | 1 | 2014 | 6 | 0.120 |
Why?
|
| DNA Primers | 2 | 2012 | 2892 | 0.120 |
Why?
|
| Proteome | 2 | 2022 | 1799 | 0.120 |
Why?
|
| Stereotaxic Techniques | 1 | 2016 | 536 | 0.120 |
Why?
|
| Histone Deacetylase 1 | 1 | 2015 | 137 | 0.120 |
Why?
|
| 1-Propanol | 1 | 2013 | 15 | 0.120 |
Why?
|
| Hospitals, Public | 2 | 2015 | 207 | 0.120 |
Why?
|
| Crosses, Genetic | 2 | 2014 | 791 | 0.120 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2015 | 190 | 0.120 |
Why?
|
| United States | 10 | 2021 | 69872 | 0.120 |
Why?
|
| Alcohol-Related Disorders | 1 | 2016 | 234 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2016 | 658 | 0.120 |
Why?
|
| Blotting, Western | 2 | 2013 | 5179 | 0.120 |
Why?
|
| DNA Copy Number Variations | 1 | 2022 | 1941 | 0.120 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2016 | 338 | 0.120 |
Why?
|
| Saliva | 2 | 2016 | 809 | 0.120 |
Why?
|
| Spermatozoa | 2 | 2018 | 625 | 0.120 |
Why?
|
| Dialysis | 1 | 2013 | 75 | 0.120 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 2013 | 107 | 0.120 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2009 | 648 | 0.120 |
Why?
|
| HLA Antigens | 1 | 2019 | 1381 | 0.120 |
Why?
|
| Serine | 1 | 2017 | 826 | 0.120 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 853 | 0.120 |
Why?
|
| Virus Cultivation | 1 | 2013 | 92 | 0.120 |
Why?
|
| Amidohydrolases | 1 | 2014 | 169 | 0.120 |
Why?
|
| Monitoring, Ambulatory | 1 | 2017 | 355 | 0.110 |
Why?
|
| Borderline Personality Disorder | 1 | 2021 | 736 | 0.110 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2015 | 211 | 0.110 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2013 | 313 | 0.110 |
Why?
|
| Autistic Disorder | 1 | 2023 | 1185 | 0.110 |
Why?
|
| Injections, Intraperitoneal | 2 | 2010 | 425 | 0.110 |
Why?
|
| Multiprotein Complexes | 1 | 2020 | 1119 | 0.110 |
Why?
|
| Methylcellulose | 1 | 2013 | 37 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 2540 | 0.110 |
Why?
|
| Parents | 2 | 2024 | 3407 | 0.110 |
Why?
|
| Ovariectomy | 1 | 2015 | 661 | 0.110 |
Why?
|
| Pregnancy | 9 | 2022 | 29144 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2016 | 3920 | 0.110 |
Why?
|
| Appetitive Behavior | 1 | 2012 | 37 | 0.110 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 1889 | 0.110 |
Why?
|
| Rodentia | 2 | 2023 | 261 | 0.110 |
Why?
|
| Carbamates | 1 | 2014 | 196 | 0.110 |
Why?
|
| Memory, Long-Term | 1 | 2013 | 64 | 0.110 |
Why?
|
| Reproducibility of Results | 7 | 2023 | 19905 | 0.110 |
Why?
|
| beta-Galactosidase | 1 | 2013 | 573 | 0.110 |
Why?
|
| Manganese Compounds | 1 | 2012 | 27 | 0.110 |
Why?
|
| Territoriality | 1 | 2011 | 6 | 0.110 |
Why?
|
| Hallucinogens | 1 | 2015 | 180 | 0.110 |
Why?
|
| Phosphorus | 1 | 2013 | 338 | 0.100 |
Why?
|
| Nitrogen | 1 | 2013 | 344 | 0.100 |
Why?
|
| Autoimmune Diseases | 1 | 2024 | 2133 | 0.100 |
Why?
|
| Diazepam | 1 | 2012 | 205 | 0.100 |
Why?
|
| DNA | 4 | 2014 | 7301 | 0.100 |
Why?
|
| Bronchodilator Agents | 1 | 2015 | 502 | 0.100 |
Why?
|
| RNA, Untranslated | 1 | 2015 | 453 | 0.100 |
Why?
|
| Visual Perception | 1 | 2020 | 1420 | 0.100 |
Why?
|
| Tobacco Use Disorder | 1 | 2017 | 688 | 0.100 |
Why?
|
| Neurosecretory Systems | 2 | 2010 | 231 | 0.100 |
Why?
|
| Illinois | 1 | 2011 | 119 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4751 | 0.100 |
Why?
|
| Selection, Genetic | 1 | 2016 | 914 | 0.100 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2012 | 117 | 0.100 |
Why?
|
| Repression, Psychology | 1 | 2011 | 44 | 0.100 |
Why?
|
| Electronics | 2 | 2023 | 322 | 0.100 |
Why?
|
| Desipramine | 1 | 2011 | 184 | 0.100 |
Why?
|
| Amino Acid Transport Systems, Neutral | 1 | 2011 | 41 | 0.100 |
Why?
|
| Pain Measurement | 3 | 2013 | 3420 | 0.100 |
Why?
|
| Brain Concussion | 1 | 2022 | 1320 | 0.100 |
Why?
|
| Oligopeptides | 1 | 2016 | 1189 | 0.100 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 905 | 0.100 |
Why?
|
| Drug Discovery | 1 | 2019 | 1058 | 0.100 |
Why?
|
| CA2 Region, Hippocampal | 1 | 2010 | 21 | 0.100 |
Why?
|
| Oxygen | 2 | 2013 | 4189 | 0.100 |
Why?
|
| Cluster Analysis | 3 | 2014 | 2715 | 0.090 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2010 | 75 | 0.090 |
Why?
|
| Personality Assessment | 1 | 2013 | 647 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 893 | 0.090 |
Why?
|
| Limonins | 1 | 2010 | 24 | 0.090 |
Why?
|
| Interferon-gamma | 1 | 2019 | 3206 | 0.090 |
Why?
|
| Inpatients | 1 | 2022 | 2518 | 0.090 |
Why?
|
| RNA, Small Interfering | 3 | 2020 | 3505 | 0.090 |
Why?
|
| Genes, Immediate-Early | 2 | 2019 | 101 | 0.090 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2013 | 306 | 0.090 |
Why?
|
| RGS Proteins | 1 | 2010 | 77 | 0.090 |
Why?
|
| Pentylenetetrazole | 1 | 2010 | 69 | 0.090 |
Why?
|
| Eye Movement Desensitization Reprocessing | 1 | 2010 | 6 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2019 | 2499 | 0.090 |
Why?
|
| Glycine | 1 | 2013 | 671 | 0.090 |
Why?
|
| Social Problems | 1 | 2011 | 112 | 0.090 |
Why?
|
| Nasal Mucosa | 1 | 1993 | 373 | 0.090 |
Why?
|
| Goals | 1 | 2015 | 706 | 0.090 |
Why?
|
| Phosphorylation | 3 | 2010 | 8436 | 0.090 |
Why?
|
| Electric Stimulation | 1 | 2015 | 1767 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 1861 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2023 | 3923 | 0.090 |
Why?
|
| Gerbillinae | 1 | 2009 | 89 | 0.090 |
Why?
|
| Signal Detection, Psychological | 1 | 2010 | 85 | 0.090 |
Why?
|
| Mothers | 3 | 2022 | 2165 | 0.090 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 1775 | 0.090 |
Why?
|
| Social Support | 2 | 2011 | 2118 | 0.090 |
Why?
|
| Conditioning, Operant | 3 | 2017 | 313 | 0.090 |
Why?
|
| Neuralgia | 1 | 2016 | 570 | 0.090 |
Why?
|
| Menstrual Cycle | 1 | 2013 | 551 | 0.090 |
Why?
|
| Primary Health Care | 3 | 2011 | 4558 | 0.090 |
Why?
|
| Executive Function | 2 | 2016 | 1364 | 0.090 |
Why?
|
| Emotional Intelligence | 1 | 2011 | 136 | 0.090 |
Why?
|
| Prevalence | 7 | 2022 | 15226 | 0.090 |
Why?
|
| Psychophysics | 1 | 2010 | 309 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2019 | 4217 | 0.090 |
Why?
|
| Models, Statistical | 5 | 2019 | 5102 | 0.090 |
Why?
|
| Extremities | 1 | 2015 | 865 | 0.090 |
Why?
|
| Child Development | 1 | 2021 | 2223 | 0.090 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2016 | 1366 | 0.090 |
Why?
|
| Phosphoproteins | 1 | 2018 | 2440 | 0.090 |
Why?
|
| RNA | 3 | 2011 | 2749 | 0.090 |
Why?
|
| Pregnant Women | 1 | 2014 | 568 | 0.090 |
Why?
|
| Communication | 1 | 2023 | 3749 | 0.090 |
Why?
|
| Child, Preschool | 6 | 2023 | 41006 | 0.090 |
Why?
|
| Pyridines | 2 | 2012 | 2825 | 0.090 |
Why?
|
| Epithelial Cells | 2 | 2019 | 3690 | 0.090 |
Why?
|
| Alzheimer Disease | 2 | 2024 | 8037 | 0.090 |
Why?
|
| Titrimetry | 1 | 2009 | 36 | 0.090 |
Why?
|
| Chlorides | 1 | 2012 | 667 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 2021 | 3589 | 0.090 |
Why?
|
| Time Factors | 9 | 2019 | 40075 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2014 | 8324 | 0.090 |
Why?
|
| Personality | 1 | 2013 | 552 | 0.080 |
Why?
|
| Limbic System | 1 | 2011 | 426 | 0.080 |
Why?
|
| Nerve Growth Factors | 2 | 2004 | 574 | 0.080 |
Why?
|
| Aminopyridines | 1 | 2013 | 542 | 0.080 |
Why?
|
| Schizotypal Personality Disorder | 1 | 2010 | 288 | 0.080 |
Why?
|
| Pentagastrin | 1 | 2008 | 17 | 0.080 |
Why?
|
| Health Policy | 1 | 2021 | 2661 | 0.080 |
Why?
|
| Polymers | 1 | 2016 | 1621 | 0.080 |
Why?
|
| Lasers | 1 | 2013 | 952 | 0.080 |
Why?
|
| Benzamides | 1 | 2014 | 1379 | 0.080 |
Why?
|
| RNA Interference | 2 | 2020 | 2889 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 898 | 0.080 |
Why?
|
| Unemployment | 1 | 2010 | 214 | 0.080 |
Why?
|
| Action Potentials | 1 | 2016 | 1806 | 0.080 |
Why?
|
| Prisoners | 1 | 2012 | 297 | 0.080 |
Why?
|
| Lithium Chloride | 1 | 2008 | 87 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2015 | 6386 | 0.080 |
Why?
|
| Mental Health | 1 | 2022 | 3019 | 0.080 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 1152 | 0.080 |
Why?
|
| GABA Plasma Membrane Transport Proteins | 1 | 2007 | 30 | 0.080 |
Why?
|
| Birth Weight | 1 | 2016 | 2069 | 0.080 |
Why?
|
| Hypertension | 2 | 2022 | 8480 | 0.080 |
Why?
|
| Pyramidal Cells | 1 | 2010 | 363 | 0.080 |
Why?
|
| Smoking | 2 | 2016 | 8987 | 0.080 |
Why?
|
| Transcription Factors | 2 | 2019 | 12208 | 0.080 |
Why?
|
| Friends | 1 | 2009 | 154 | 0.080 |
Why?
|
| Psychological Tests | 3 | 2019 | 651 | 0.080 |
Why?
|
| Domestic Violence | 1 | 2009 | 176 | 0.080 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2022 | 2737 | 0.070 |
Why?
|
| Genetics, Population | 2 | 2014 | 934 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2010 | 1682 | 0.070 |
Why?
|
| Transduction, Genetic | 2 | 2008 | 913 | 0.070 |
Why?
|
| Genome, Human | 3 | 2015 | 4420 | 0.070 |
Why?
|
| Prognosis | 4 | 2021 | 29063 | 0.070 |
Why?
|
| International Cooperation | 1 | 2013 | 1420 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2012 | 1285 | 0.070 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2010 | 503 | 0.070 |
Why?
|
| Functional Laterality | 1 | 2013 | 2290 | 0.070 |
Why?
|
| Receptor, PAR-1 | 1 | 2007 | 113 | 0.070 |
Why?
|
| Electrolysis | 1 | 2006 | 9 | 0.070 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2008 | 430 | 0.070 |
Why?
|
| Frontal Lobe | 1 | 2013 | 1406 | 0.070 |
Why?
|
| Models, Biological | 2 | 2021 | 9583 | 0.070 |
Why?
|
| Hospitalization | 3 | 2022 | 10262 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 2505 | 0.070 |
Why?
|
| High-Throughput Screening Assays | 1 | 2012 | 944 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2008 | 354 | 0.070 |
Why?
|
| Antimetabolites | 1 | 2006 | 125 | 0.070 |
Why?
|
| Apomorphine | 1 | 2006 | 150 | 0.070 |
Why?
|
| Neocortex | 1 | 2010 | 400 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 3617 | 0.070 |
Why?
|
| Universities | 1 | 2011 | 956 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 2916 | 0.070 |
Why?
|
| Pentanols | 1 | 2005 | 4 | 0.070 |
Why?
|
| Logistic Models | 3 | 2016 | 13408 | 0.070 |
Why?
|
| Patient Readmission | 1 | 2019 | 3114 | 0.070 |
Why?
|
| Software | 2 | 2021 | 4443 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 1602 | 0.060 |
Why?
|
| Aged, 80 and over | 7 | 2022 | 57776 | 0.060 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 1940 | 0.060 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 4186 | 0.060 |
Why?
|
| Histones | 1 | 2015 | 2599 | 0.060 |
Why?
|
| Time | 2 | 2018 | 542 | 0.060 |
Why?
|
| Infant, Newborn | 5 | 2023 | 25625 | 0.060 |
Why?
|
| Syndrome | 1 | 2011 | 3251 | 0.060 |
Why?
|
| Indole Alkaloids | 1 | 2004 | 24 | 0.060 |
Why?
|
| Neurology | 1 | 2013 | 763 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2010 | 2726 | 0.060 |
Why?
|
| Radiography | 1 | 2015 | 7023 | 0.060 |
Why?
|
| Cross-Cultural Comparison | 1 | 2008 | 651 | 0.060 |
Why?
|
| Viral Load | 1 | 2013 | 3299 | 0.060 |
Why?
|
| Age Factors | 3 | 2019 | 18370 | 0.060 |
Why?
|
| Suicidal Ideation | 3 | 2019 | 1248 | 0.060 |
Why?
|
| Organ Specificity | 2 | 2014 | 2008 | 0.060 |
Why?
|
| Laboratories | 1 | 2007 | 463 | 0.060 |
Why?
|
| Plasmids | 1 | 2009 | 2307 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2007 | 2327 | 0.060 |
Why?
|
| Vascular Diseases | 1 | 2012 | 1161 | 0.060 |
Why?
|
| Transgenes | 1 | 2007 | 1009 | 0.060 |
Why?
|
| Heterozygote | 1 | 2010 | 2804 | 0.060 |
Why?
|
| Sirolimus | 1 | 2010 | 1564 | 0.060 |
Why?
|
| Neurogranin | 1 | 2002 | 15 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 2016 | 3848 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2007 | 1730 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 39050 | 0.050 |
Why?
|
| DNA, Circular | 1 | 2022 | 97 | 0.050 |
Why?
|
| Carbazoles | 1 | 2004 | 226 | 0.050 |
Why?
|
| Entorhinal Cortex | 1 | 2024 | 272 | 0.050 |
Why?
|
| Drug Prescriptions | 1 | 2012 | 1637 | 0.050 |
Why?
|
| Kainic Acid | 1 | 2002 | 199 | 0.050 |
Why?
|
| Testosterone | 1 | 2013 | 2420 | 0.050 |
Why?
|
| Darkness | 2 | 2012 | 167 | 0.050 |
Why?
|
| Thalamic Nuclei | 1 | 2022 | 114 | 0.050 |
Why?
|
| Neurites | 1 | 2024 | 388 | 0.050 |
Why?
|
| Cold Temperature | 1 | 2005 | 772 | 0.050 |
Why?
|
| Psychotic Disorders | 1 | 2016 | 3046 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2004 | 880 | 0.050 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2002 | 249 | 0.050 |
Why?
|
| User-Computer Interface | 1 | 2008 | 1431 | 0.050 |
Why?
|
| Genetic Engineering | 1 | 2007 | 951 | 0.050 |
Why?
|
| Neurofilament Proteins | 1 | 2002 | 318 | 0.050 |
Why?
|
| Afghanistan | 1 | 2020 | 81 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2012 | 2942 | 0.050 |
Why?
|
| Principal Component Analysis | 2 | 2014 | 940 | 0.050 |
Why?
|
| Reference Values | 2 | 2019 | 4982 | 0.050 |
Why?
|
| T-Lymphocytes | 2 | 2022 | 10180 | 0.050 |
Why?
|
| Unconsciousness | 1 | 2022 | 263 | 0.050 |
Why?
|
| Leukocytes | 2 | 2020 | 2043 | 0.050 |
Why?
|
| Kynurenine | 1 | 2020 | 139 | 0.050 |
Why?
|
| Placebos | 1 | 2004 | 1676 | 0.040 |
Why?
|
| Circadian Rhythm | 2 | 2022 | 2624 | 0.040 |
Why?
|
| Receptors, Adrenergic | 1 | 2000 | 155 | 0.040 |
Why?
|
| Behavior Therapy | 1 | 2005 | 865 | 0.040 |
Why?
|
| Meta-Analysis as Topic | 2 | 2017 | 1344 | 0.040 |
Why?
|
| Policy | 1 | 2023 | 508 | 0.040 |
Why?
|
| Occipital Lobe | 1 | 2021 | 379 | 0.040 |
Why?
|
| Drug Utilization | 1 | 2006 | 1183 | 0.040 |
Why?
|
| Deep Brain Stimulation | 1 | 2007 | 748 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 2699 | 0.040 |
Why?
|
| Shame | 1 | 2019 | 78 | 0.040 |
Why?
|
| ROC Curve | 2 | 2021 | 3527 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2024 | 495 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2011 | 1797 | 0.040 |
Why?
|
| Cyclohexenes | 1 | 2018 | 15 | 0.040 |
Why?
|
| Receptors, Serotonin | 1 | 2000 | 201 | 0.040 |
Why?
|
| Epithelium | 4 | 2004 | 1679 | 0.040 |
Why?
|
| 14-3-3 Proteins | 1 | 2020 | 214 | 0.040 |
Why?
|
| Oligodendroglia | 1 | 2022 | 517 | 0.040 |
Why?
|
| Reproduction | 2 | 2017 | 668 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2019 | 352 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2004 | 1224 | 0.040 |
Why?
|
| Cordocentesis | 1 | 2018 | 8 | 0.040 |
Why?
|
| Contrast Media | 1 | 2012 | 5300 | 0.040 |
Why?
|
| Exons | 1 | 2004 | 2437 | 0.040 |
Why?
|
| Locus Coeruleus | 1 | 1999 | 176 | 0.040 |
Why?
|
| Algorithms | 3 | 2020 | 13881 | 0.040 |
Why?
|
| Germany | 2 | 2011 | 862 | 0.040 |
Why?
|
| Infant | 4 | 2023 | 35136 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2010 | 4554 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 7722 | 0.040 |
Why?
|
| Canada | 1 | 2023 | 2065 | 0.040 |
Why?
|
| Antibodies, Protozoan | 1 | 2019 | 253 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 4149 | 0.040 |
Why?
|
| Aldehydes | 1 | 2018 | 167 | 0.040 |
Why?
|
| Histocompatibility Testing | 1 | 2019 | 741 | 0.040 |
Why?
|
| Norway | 1 | 2018 | 448 | 0.040 |
Why?
|
| Neurophysiology | 1 | 2018 | 142 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2024 | 2375 | 0.040 |
Why?
|
| Reference Standards | 1 | 2021 | 1025 | 0.040 |
Why?
|
| Jews | 1 | 2019 | 385 | 0.040 |
Why?
|
| Multigene Family | 3 | 1996 | 1102 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2016 | 122 | 0.040 |
Why?
|
| Obesity | 2 | 2022 | 12745 | 0.040 |
Why?
|
| Pain Perception | 1 | 2018 | 191 | 0.040 |
Why?
|
| Lateral Ventricles | 1 | 2017 | 146 | 0.040 |
Why?
|
| Asthma | 1 | 2015 | 6011 | 0.040 |
Why?
|
| Personality Disorders | 1 | 2021 | 713 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2019 | 767 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2019 | 11725 | 0.030 |
Why?
|
| Sensation | 1 | 2018 | 336 | 0.030 |
Why?
|
| Nose | 3 | 1996 | 509 | 0.030 |
Why?
|
| Sleep | 2 | 2023 | 4623 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2023 | 1357 | 0.030 |
Why?
|
| Neuroanatomical Tract-Tracing Techniques | 1 | 2015 | 40 | 0.030 |
Why?
|
| Elongation Factor 2 Kinase | 1 | 2015 | 10 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2013 | 12720 | 0.030 |
Why?
|
| Allosteric Site | 1 | 2015 | 103 | 0.030 |
Why?
|
| Microglia | 1 | 2024 | 1266 | 0.030 |
Why?
|
| Trauma Centers | 1 | 2021 | 890 | 0.030 |
Why?
|
| Multilevel Analysis | 1 | 2015 | 142 | 0.030 |
Why?
|
| Injections | 1 | 2018 | 840 | 0.030 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2016 | 284 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 3507 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2022 | 1425 | 0.030 |
Why?
|
| Outpatients | 2 | 2018 | 1486 | 0.030 |
Why?
|
| Species Specificity | 1 | 2019 | 2478 | 0.030 |
Why?
|
| Metabolomics | 1 | 2023 | 1484 | 0.030 |
Why?
|
| Endothelin-1 | 1 | 2016 | 314 | 0.030 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2015 | 107 | 0.030 |
Why?
|
| Rhode Island | 1 | 2015 | 347 | 0.030 |
Why?
|
| Epilepsy | 1 | 2010 | 3310 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2019 | 9146 | 0.030 |
Why?
|
| Disease Progression | 1 | 2011 | 13284 | 0.030 |
Why?
|
| Germ Cells | 1 | 2018 | 631 | 0.030 |
Why?
|
| Puerto Rico | 1 | 2015 | 356 | 0.030 |
Why?
|
| Nepal | 1 | 2015 | 295 | 0.030 |
Why?
|
| Parent-Child Relations | 1 | 2019 | 747 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2018 | 692 | 0.030 |
Why?
|
| Marijuana Abuse | 1 | 2018 | 403 | 0.030 |
Why?
|
| Perception | 1 | 2020 | 1198 | 0.030 |
Why?
|
| Molecular Sequence Data | 4 | 1996 | 18111 | 0.030 |
Why?
|
| Genome | 1 | 2022 | 1808 | 0.030 |
Why?
|
| Heart Failure | 1 | 2018 | 10900 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2021 | 1783 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 1994 | 311 | 0.030 |
Why?
|
| Computer Simulation | 2 | 2019 | 6196 | 0.030 |
Why?
|
| Endosomes | 1 | 2016 | 520 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 12245 | 0.030 |
Why?
|
| Calcium Channels | 1 | 2017 | 622 | 0.030 |
Why?
|
| Human Characteristics | 1 | 2013 | 7 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2019 | 2297 | 0.030 |
Why?
|
| Cholesterol | 1 | 2022 | 2917 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 1994 | 13815 | 0.030 |
Why?
|
| Placebo Effect | 1 | 2017 | 502 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 2016 | 655 | 0.030 |
Why?
|
| Endocytosis | 2 | 2010 | 985 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3798 | 0.030 |
Why?
|
| Peptide Elongation Factor 1 | 1 | 2012 | 40 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2015 | 499 | 0.030 |
Why?
|
| Catheterization | 2 | 2013 | 1470 | 0.030 |
Why?
|
| Sciatic Nerve | 1 | 2016 | 607 | 0.030 |
Why?
|
| South Africa | 1 | 2018 | 1731 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2017 | 1792 | 0.030 |
Why?
|
| Receptors, Thrombin | 1 | 2013 | 131 | 0.030 |
Why?
|
| Age Distribution | 1 | 2019 | 2902 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2016 | 810 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1993 | 878 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2020 | 1613 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2017 | 1677 | 0.030 |
Why?
|
| Genes, RAG-1 | 1 | 2012 | 68 | 0.030 |
Why?
|
| Mentally Ill Persons | 1 | 2013 | 126 | 0.030 |
Why?
|
| Longevity | 1 | 2020 | 1070 | 0.030 |
Why?
|
| Arrhythmia, Sinus | 1 | 2012 | 56 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2019 | 1547 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1994 | 2839 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 708 | 0.030 |
Why?
|
| Receptors, Peptide | 1 | 2013 | 272 | 0.030 |
Why?
|
| Raphe Nuclei | 1 | 2012 | 104 | 0.030 |
Why?
|
| Mesocricetus | 1 | 2011 | 252 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2018 | 1318 | 0.030 |
Why?
|
| Interleukin-18 Receptor alpha Subunit | 1 | 2011 | 18 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2010 | 3846 | 0.020 |
Why?
|
| Cities | 1 | 2014 | 513 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 1708 | 0.020 |
Why?
|
| Psychotherapy, Brief | 1 | 2012 | 114 | 0.020 |
Why?
|
| Behavioral Symptoms | 1 | 2013 | 175 | 0.020 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2012 | 346 | 0.020 |
Why?
|
| Research Design | 2 | 2019 | 5987 | 0.020 |
Why?
|
| Tritium | 1 | 2011 | 745 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2008 | 5137 | 0.020 |
Why?
|
| Respiratory Rate | 1 | 2012 | 162 | 0.020 |
Why?
|
| Auditory Perception | 1 | 2015 | 569 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2010 | 104 | 0.020 |
Why?
|
| Forecasting | 1 | 2019 | 2951 | 0.020 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 1989 | 64 | 0.020 |
Why?
|
| Homovanillic Acid | 1 | 1989 | 75 | 0.020 |
Why?
|
| Chromosome Mapping | 2 | 2015 | 4740 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2008 | 5319 | 0.020 |
Why?
|
| Valine | 1 | 2011 | 413 | 0.020 |
Why?
|
| Receptors, Vasopressin | 1 | 2010 | 112 | 0.020 |
Why?
|
| Food Deprivation | 1 | 1989 | 116 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2015 | 942 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2011 | 462 | 0.020 |
Why?
|
| Prejudice | 1 | 2014 | 570 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2012 | 844 | 0.020 |
Why?
|
| Calcium | 1 | 2022 | 5756 | 0.020 |
Why?
|
| Methionine | 1 | 2011 | 590 | 0.020 |
Why?
|
| Receptors, Neuropeptide Y | 1 | 2008 | 44 | 0.020 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2010 | 315 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2011 | 576 | 0.020 |
Why?
|
| Angiotensin II | 1 | 2012 | 881 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 1855 | 0.020 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2017 | 1004 | 0.020 |
Why?
|
| Arginine Vasopressin | 1 | 2008 | 130 | 0.020 |
Why?
|
| Students | 1 | 2018 | 1654 | 0.020 |
Why?
|
| Pedigree | 1 | 2016 | 4644 | 0.020 |
Why?
|
| Healthcare Disparities | 2 | 2017 | 3158 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2022 | 6256 | 0.020 |
Why?
|
| Biophysical Phenomena | 1 | 2009 | 327 | 0.020 |
Why?
|
| Sexual Behavior | 1 | 2017 | 2057 | 0.020 |
Why?
|
| Cricetinae | 1 | 2011 | 2472 | 0.020 |
Why?
|
| Sexual Behavior, Animal | 1 | 2008 | 113 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 4803 | 0.020 |
Why?
|
| Motivation | 1 | 2017 | 1971 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 1504 | 0.020 |
Why?
|
| Biophysics | 1 | 2009 | 383 | 0.020 |
Why?
|
| Receptors, Purinergic P2Y2 | 1 | 2007 | 18 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2017 | 3200 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2013 | 867 | 0.020 |
Why?
|
| Receptors, Purinergic P2Y1 | 1 | 2007 | 40 | 0.020 |
Why?
|
| Swimming | 1 | 2008 | 206 | 0.020 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2007 | 64 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2011 | 1901 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2021 | 77449 | 0.020 |
Why?
|
| Mother-Child Relations | 1 | 2011 | 481 | 0.020 |
Why?
|
| Lac Operon | 1 | 2007 | 238 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2017 | 5078 | 0.020 |
Why?
|
| Causality | 1 | 2013 | 1275 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 4560 | 0.020 |
Why?
|
| Axons | 1 | 1994 | 1684 | 0.020 |
Why?
|
| Boston | 1 | 2019 | 9313 | 0.020 |
Why?
|
| Transportation | 1 | 2008 | 214 | 0.020 |
Why?
|
| Health Surveys | 1 | 2016 | 4037 | 0.020 |
Why?
|
| Cell Membrane | 2 | 2007 | 3748 | 0.020 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2007 | 153 | 0.020 |
Why?
|
| Genes | 1 | 2010 | 1893 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 2109 | 0.020 |
Why?
|
| Flunitrazepam | 1 | 2005 | 20 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2009 | 1137 | 0.020 |
Why?
|
| Analgesics | 1 | 2012 | 1040 | 0.020 |
Why?
|
| Protein Binding | 2 | 2010 | 9386 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 970 | 0.020 |
Why?
|
| Arginine | 1 | 2008 | 944 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 3327 | 0.020 |
Why?
|
| Smoking Cessation | 1 | 2016 | 2071 | 0.020 |
Why?
|
| Computational Biology | 1 | 2016 | 3521 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 15076 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2010 | 3701 | 0.010 |
Why?
|
| Lysine | 1 | 2009 | 1007 | 0.010 |
Why?
|
| Motor Skills | 1 | 2007 | 522 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2016 | 5097 | 0.010 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2004 | 104 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1993 | 6171 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 3597 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2012 | 4204 | 0.010 |
Why?
|
| Pandemics | 1 | 2023 | 8388 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2018 | 6150 | 0.010 |
Why?
|
| Family Health | 1 | 2008 | 1282 | 0.010 |
Why?
|
| Photosensitizing Agents | 1 | 2007 | 602 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2019 | 4468 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 1790 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2012 | 5456 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 2002 | 419 | 0.010 |
Why?
|
| Body Weight | 1 | 2012 | 4669 | 0.010 |
Why?
|
| Pyrrolidinones | 1 | 2002 | 117 | 0.010 |
Why?
|
| Base Sequence | 1 | 1993 | 12797 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 2002 | 624 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2012 | 5524 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 3760 | 0.010 |
Why?
|
| Equipment Design | 1 | 2008 | 3582 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 4931 | 0.010 |
Why?
|
| Protein Transport | 1 | 2004 | 1988 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 1970 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2011 | 6442 | 0.010 |
Why?
|
| Liver | 1 | 1993 | 7474 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2012 | 8554 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 14722 | 0.010 |
Why?
|
| Cations | 1 | 1995 | 232 | 0.010 |
Why?
|
| Health Status | 1 | 2008 | 4034 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1996 | 1085 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1995 | 964 | 0.010 |
Why?
|
| Apoptosis | 1 | 2010 | 9727 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 16689 | 0.010 |
Why?
|
| Vertebrates | 1 | 1994 | 227 | 0.010 |
Why?
|
| Mental Health Services | 1 | 2004 | 1643 | 0.010 |
Why?
|
| Kidney | 1 | 2007 | 7186 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1995 | 970 | 0.010 |
Why?
|
| Ion Channels | 1 | 1995 | 1056 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1996 | 2421 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 4320 | 0.010 |
Why?
|
| Cilia | 1 | 1994 | 466 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1994 | 2256 | 0.010 |
Why?
|
| Mass Screening | 1 | 2004 | 5255 | 0.000 |
Why?
|
| Extracellular Space | 1 | 1989 | 594 | 0.000 |
Why?
|
| Amino Acids | 1 | 1989 | 1736 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1995 | 11483 | 0.000 |
Why?
|
| Diet | 1 | 1989 | 7939 | 0.000 |
Why?
|
| Mutation | 1 | 1995 | 29786 | 0.000 |
Why?
|